Relationship between uterine natural killer cells and unexplained repeated miscarriage

Journal of the Turkish German Gynecology Association

Volumn 16, Issue 4, 2015, Pages 214-218

  Farghali, Mohamed M ^a   El Kholy, Abdel Latif G ^a   Swidan, Khaled H ^a   Abdelazim, Ibrahim A ^a,b   Rashed, Ahmed R ^a   El Sobky, Ezzat ^c   Goma, Mostafa F ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b KUWAIT OIL COMPANY   (Kuwait)

^c AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Obstetrics; Repeated miscarriage; Uterine killer cells

Indexed keywords

CD16 ANTIGEN; CD56 ANTIGEN;

ADULT; ANEUPLOIDY; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FETAL WELL BEING; GESTATIONAL AGE; HUMAN; HUMAN CELL; KARYOTYPING; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MISSED ABORTION; NATURAL KILLER CELL; PATHOGENESIS; RECURRENT ABORTION; TETRAPLOIDY; TRIPLOIDY;

EID: 84948141355     PISSN: 13090399     EISSN: 13090380     Source Type: Journal    
DOI: 10.5152/jtgga.2015.0082     Document Type: Article

References (41)

1. Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss. Fertil Steril 2008; 89:1603.
2. Bricker L, Farquharson RG. Types of pregnancy loss in recurrent miscarriage: implications for research and clinical practice. Hum Reprod 2002; 17: 1345-50.
3. Kiwi R. Recurrent pregnancy loss: evaluation and discussion of the causes and their management. Cleve Clin J Med 2006; 73: 913-21.
4. Christiansen OB, Nybo Andersen AM, Bosch E, Daya S, Delves PJ, Hviid TV, et al. Evidenced-based investigations and treatments of recurrent pregnancy loss. Fertil Steril 2005; 83: 821-39.
5. Egozcue S, Balanco J, Vendrell JM, García F, Veiga A, Aran B, et al. Human male infertility: chromosomal abnormalities, meiotic disorders, abnormal spermatozoa and recurrent abortion. Hum Reprod 2000; 6; 93-105.
6. Wilcox AJ, Weinberg CR, O’Connor JF, Baird DD, Schlatterer JP, Canfield RE, et al. Incidence of early loss of pregnancy. N Engl J Med 1988; 319: 189-94.
7. Rai R, Regan L. Recurent miscarriage. Lancet 2006; 368: 601-11.
8. Summers PR. Microbiology relevant to recurrent miscarriage. Clin Obstet Gynecol 1994; 37: 722-9.
9. Matovina M, Husnjak K, Milutin N, Ciglar S, Grce M. Possible role of bacterial and viral infections in miscarriages. Fertil Steril 2004; 81: 662-9.
10. Abramson J, Stagnaro-Green A. Thyroid antibodies and fetal loss: an evolving story. Thyroid 2001; 11: 57-63.
11. Moffett-King A. Natural Killer cells and pregnancy. Nat Rev Immunol 2002; 2: 656-63.
12. Yovel G, Shakhar K, Ben-Eliyahu S. The effects of sex, menstrual cycle, and oral contraceptives on the number and activity of natural killer cells. Gynecol Oncol 2001; 81: 254-62.
13. Bilinski MJ, Thorne JG, Oh MJ, Leonard S, Murrant C, Tayade C, Croy BA. Uterine NK cells in murine pregnancy. Reprod Biomed Online 2008; 16: 218-26.
14. Murphy SP, Fast LD, Hanna NN, Sharma S. Uterine natural killer cells mediate inflammation-induced fetal demise in IL-10 null mice. J Immunol 2005; 175: 4084-90.
15. Lash GE, Bulmer JN. Do uterine natural killer (uNK) cells contribute to female reproductive disorders? J Reprod Immunol 2011; 88: 156-64.
16. Quenby S, Farquharson R. Uterine natural killer cells, implantation failure and recurrent miscarriage. Reprod Biomed Online 2006; 13: 24-8.
17. Emmer PM, Nelen WL, Steegers EA, Hendriks JC, Veerhoek M, Joosten L. Peripheral natural killer cytotoxicity and CD56(pos) CD16(pos) cells increase during early pregnancy in women with a history of recurrent spontaneous abortion. Hum Reprod 2000; 15: 1163-9.
18. Thum MY, Haskaran SB, Bansal AS, Shehata H, Ford B, Sumar N, Abdalla HI. Simple enumerations of peripheral blood natural killer (CD56+ NK) cells, B cells and T cells have no predictive value in IVF treatment outcome. Hum Reprod 2005; 20: 1272-6.
19. Gilman-Sachs A, Duchateau BK, AslaKson CJ, Wohlgmuth GP, Kwak JY, Beer AE, Beaman KD. Natural Killer (NK) cell subsets and NK cell cytotoxicity in women with histories of recurrent spontaneous abortions. Am J Reprod Immunol 1999; 41: 99-105.
20. Quenby S, Kalumbi C, Bates M, Farquharson RG, Vince G. Prednisolone reduces preconceptual endometrial natural killer cells in women with recurrent miscarriage. Fertil Steril 2005; 84: 980-4.
21. Shimada S, Kato EH, Morikawa M, Iwabuchi K, Nishida R, Kishi R, et al. No difference in natural killer or natural killer T-cell population, but aberrant T-helper cell population in the endometrium of women with repeated miscarriage. Hum Reprod 2004; 19: 1018-24.
22. Quenby S, Nik H, Innes B, Lash G, Turner M, Drury J, Bulmer J. Uterine natural killer cells and angiogenesis in recurrent reproductive failure. Hum Reprod 2009; 24: 45-54.
23. Pongcharoen S, Searle RF, Bulmer JN. Placental Fas and Fas ligand expression in normal early, term and molar pregnancy. Placenta 2004; 25: 32I-30.
24. Saito S. Cytokine network at the feto-maternal interface. J Reprod Immunol 2000; 47: 87-103.
25. Bansal AS. Joining the immunological dots in recurrent miscarriage. Am J Reprod Immunol 2010; 64: 307-15.
26. Thum M, Bhaskaran S, Abdallah HI, Ford B, Sumar N, Bansal AS. Prednisolone suppresses nK cell cytotoxicity in vitro in women with a history of infertility and elevated nK cell cytotoxicity. Am J reprod Immunol 2008; 59: 259-65.
27. Tang AW, Alfirevic Z, Turner MA, Drury JA, Small R, Quenby S. A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant. Hum Reprod 2013; 28: 1743-175.
28. Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register study. BMJ 2000; 320: 1708-12.
29. Wang JX, Davies MJ, Norman RJ. Infertility Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment. Hum Reprod 2001; 16: 2606-9.
30. Fedoresak P, Storeng R, Dale PO, Tanbo T, Abyholm T. Obesity is a risk factor for recurrent pregnancy loss after IVF or ICSI. Acta Obstet Gynecol Scand 2000; 79: 43-8.
31. Goddijn, M, Leschot, NJ. Genetic aspects of miscarriage. Baillieres Best Pract Res Clin Obstet Gynaecol 2000; 14: 855-65.
32. Stern JJ, Dorfmann MD, Gutierrez-Najar AJ, Cerrillo M, Coulam CB. Frequency of abnormal karyotypes among abortuses from women with and without a history of recurrent spontaneous abortion. Fertil Steril 1996; 65: 250-3.
33. Carp H, Toddler V, Aviram A, Daniely M, Mashiach S, Barkai G. Karyotype of the abortus in recurrent miscarriage. Fertil Steril 2001; 75: 678-82.
34. Ogasawara M, Aoki K, Okada S, Suzumori K. Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril 2000; 73: 300-34.
35. Stephenson M, Awartani KA, Robinson WP. Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a casecontrol study. Hum Reprod 2002; 17: 446-51.
36. Warburton D, Kline J, Stein Z, Hutzler M, Chin A, Hassold T. Does the karyotype of a spontaneous abortion predict the karyotype of a subsequent abortion? Evidence from 273 women with two karyotyped spontaneous abortions. Am J Hum Genet 1987; 41: 465-83.
37. Clifford K, Flanagan AM, Regan L. Endometrial CD56_natural killer cells in women with recurrent miscarriage: a histomorphometric study. Hum Reprod 1999; 14: 2727-30.
38. Emmer PM, Steegers EA, Kerstens HM, Bulten J, Nelen WL, Boer K, Joosten I. Altered phenotype of HLA-G expressing trophoblast and decidual natural killer cells in pathological pregnancies. Hum Reprod 2002; 17: 1072-80.
39. Quenby S, Bates M, Doig T, Brewster J, Lewis-Jones DI, Johnson PM, Vince G. Pre-implantation endometrial leukocytes in women with recurrent miscarriage. Hum Reprod 1999; 14: 2386-91.
40. Lachapelle MH, Miron P, Hemmings R, Roy DC. Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. Altered profile and pregnancy outcome. J Immunol 1996; 156: 4027-34.
41. Yamamoto T, Takahashi Y, Kase N, Mori H. Role of decidual Natural killer cells in patients with missed abortion: differences between cases with normal and abnormal chromosome. Clin Exp Immunol 1999; 116: 449-52.